NUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INC

NUREXONE BIOLOGIC INC

No trades
See on Supercharts

Price target

2.840.000.00%
The 2 analysts offering 1 year price forecasts for NRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to NRX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NRX EPS for the last quarter is −0.03 CAD despite the estimation of −0.04 CAD. In the next quarter EPS is expected to reach −0.03 CAD. Track more of NUREXONE BIOLOGIC INC financials and stay on top of what is up with the company.
In the next quarter NUREXONE BIOLOGIC INC revenue is expected to reach 0.00 CAD. Check out NUREXONE BIOLOGIC INC revenue and earnings and make informed decisions.
According to analysts, NRX price target is 2.84 CAD with a max estimate of 3.06 CAD and a min estimate of 2.61 CAD. Check if this forecast comes true in a year, meanwhile watch NUREXONE BIOLOGIC INC stock price chart and keep track of the current situation with NRX news and stock market news.